Learning Center

The Use of Cell Therapies for Autoimmune Diseases: CAR-T

Recorded On: 01/26/2024

  • Register
    • Non-member - $600
    • Advanced Practice Professional Member - $175
    • Industry Community - $350
    • Industry Community Sub Account - $350
    • Laboratory Member - $175
    • Laboratory Technologist Sub Account - $175
    • Laboratory Regular Member Sub Account - $175
    • Laboratory Resident and Fellow Sub Account - $175
    • Non-member Advanced Practice Professional - $600
    • Non-member Regular - $600
    • Non-member Resident or Fellow - $600
    • Non-member Technologist - $600
    • Regular Member - $200
    • Resident or Fellow Member - $150
    • Student Member - $150
    • Technologist Member - $175

The on-demand course is approximately 7 hours in length. You will have 90 days to complete it at your own pace.

Participants will receive a Certificate of Completion upon finishing all modules and achieving a minimum score of 70% on the assessments (two attempts are allowed).
Additionally, you will receive a Certificate of Participation after submitting the course evaluation survey.


Key:

Complete
Failed
Available
Locked
Acknowledgement
Agree to terms to continue.
Agree to terms to continue. Non-Distribution Statement for Content and Exam Materials
Session 1: Overview of CAR-T Cell Therapy: Past, Present and Future of CAR-T
OVERVIEW OF CAR-T CELL THERAPY: PAST, PRESENT AND FUTURE OF CAR-T
Open to view video.
Open to view video. Speaker: Bruce Levine, PhD Barbara and Edward Netter Professor, University of Pennsylvania, United States
OVERVIEW OF CAR-T CELL THERAPY: PAST, PRESENT AND FUTURE OF CAR-T
Open to download resource.
Open to download resource. Speaker: Bruce Levine, PhD Barbara and Edward Netter Professor, University of Pennsylvania, United States
Session 2: B CELL AND AUTOIMMUNITY
B CELL AND AUTOIMMUNITY
Open to view video.
Open to view video. Speaker: Karin Tarte, Pharm D, PhD Director UMR U1236-MOBIDIC, Head of Honeycomb Research Team, Head of the Immunology Lab at Rennes University Hospital, Head of Rennes Immunomonitoring Platform (SITI), Medical School of Rennes, France
B CELL AND AUTOIMMUNITY
Open to download resource.
Open to download resource. Speaker: Karin Tarte, Pharm D, PhD Director UMR U1236-MOBIDIC, Head of Honeycomb Research Team, Head of the Immunology Lab at Rennes University Hospital, Head of Rennes Immunomonitoring Platform (SITI), Medical School of Rennes, France
Session 3: TARGETED BIOLOGICAL THERAPIES IN AUTOIMMUNE DISEASES
TARGETED BIOLOGICAL THERAPIES IN AUTOIMMUNE DISEASES
Open to view video.
Open to view video. Speaker:Tobias Alexander, MD Senior Physician, Head of the Rheumatology Outpatient Clinic, Charité – Berlin University Medicine Germany
TARGETED BIOLOGICAL THERAPIES IN AUTOIMMUNE DISEASES
Open to download resource.
Open to download resource. Speaker:Tobias Alexander, MD Senior Physician, Head of the Rheumatology Outpatient Clinic, Charité – Berlin University Medicine Germany
Session 4: CAR-T IN AUTOIMMUNE DISEASES: FROM CONCEPT TO REALITY
CAR-T IN AUTOIMMUNE DISEASES: FROM CONCEPT TO REALITY
Open to view video.
Open to view video. Speaker: Georg Schett, MD, PhD Vice President of Research & Head of Department of Internal Medicine, University of Erlangen–Nuremberg Germany
CAR-T IN AUTOIMMUNE DISEASES: FROM CONCEPT TO REALITY
Open to download resource.
Open to download resource. Speaker: Georg Schett, MD, PhD Vice President of Research & Head of Department of Internal Medicine, University of Erlangen–Nuremberg Germany
Session 5: SLE TREATMENT AND PROGNOSIS
SLE TREATMENT AND PROGNOSIS
Open to view video.
Open to view video. Speaker: Andrea Doria, MD, PhD Head of the Rheumatology Unit, Department of Medicine, Padova University School of Medicine, Italy
SLE TREATMENT AND PROGNOSIS
Open to download resource.
Open to download resource. Speaker: Andrea Doria, MD, PhD Head of the Rheumatology Unit, Department of Medicine, Padova University School of Medicine, Italy
Session 6: CAR-T ANTI-CD19 IN SEVERE LUPUS
CAR-T ANTI-CD19 IN SEVERE LUPUS
Open to view video.
Open to view video. Speaker: Fabian Muller, MD Head of Research Group in Molecular Immunotherapy University Hospital Erlangen, Germany
CAR-T ANTI-CD19 IN SEVERE LUPUS
Open to download resource.
Open to download resource. Speaker: Fabian Muller, MD Head of Research Group in Molecular Immunotherapy University Hospital Erlangen, Germany
Session 7: CAR-T REGS IN LUPUS
CAR-T REGS IN LUPUS
Open to view video.
Open to view video. Speaker: Raffaella Greco, MD Senior Hematologist, Hematology & Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Italy
CAR-T REGS IN LUPUS
Open to download resource.
Open to download resource. Speaker: Raffaella Greco, MD Senior Hematologist, Hematology & Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Italy
Session 8: CONSIDERATIONS ON LYMPHODEPLETION FOR AUTOIMMUNE DISEASE PATIENTS
CONSIDERATIONS ON LYMPHODEPLETION FOR AUTOIMMUNE DISEASE PATIENTS
Open to view video.
Open to view video. Speaker: Jaap Jan Boelens, MD, PhD Chief Pediatric-Oncologist, Transplantation and Cellular Therapies, Memorial Sloan Kettering Cancer Center, United States
CONSIDERATIONS ON LYMPHODEPLETION FOR AUTOIMMUNE DISEASE PATIENTS
Open to download resource.
Open to download resource. Speaker: Jaap Jan Boelens, MD, PhD Chief Pediatric-Oncologist, Transplantation and Cellular Therapies, Memorial Sloan Kettering Cancer Center, United States
Session 9: IMMUNE MONITORING AND IMMUNE RECONSTITUTION AFTER CAR-T INJECTION IN AUTOIMMUNE DISEASES
IMMUNE MONITORING AND IMMUNE RECONSTITUTION AFTER CAR-T INJECTION IN AUTOIMMUNE DISEASES
Open to view video.
Open to view video. Speaker: Andreas Mackensen, MD Deputy Director of the CCC Erlangen-EMN, Director of the Medical Clinic 5 (Hematology and Internal Oncology), University Hospital Erlangen, Germany
IMMUNE MONITORING AND IMMUNE RECONSTITUTION AFTER CAR-T INJECTION IN AUTOIMMUNE DISEASES
Open to download resource.
Open to download resource. Speaker: Andreas Mackensen, MD Deputy Director of the CCC Erlangen-EMN, Director of the Medical Clinic 5 (Hematology and Internal Oncology), University Hospital Erlangen, Germany
Session 10: IS THERE A PLACE FOR CAR-T IN RHEUMATIC ARTHRITIS
IS THERE A PLACE FOR CAR-T IN RHEUMATIC ARTHRITIS
Open to view video.
Open to view video. Speaker: Doron Rimar, MD Senior Physician, Director of the Rheumatology Daycare Center, Bnai Zion Medical Center, Israel
IS THERE A PLACE FOR CAR-T IN RHEUMATIC ARTHRITIS
Open to download resource.
Open to download resource. Speaker: Doron Rimar, MD Senior Physician, Director of the Rheumatology Daycare Center, Bnai Zion Medical Center, Israel
Session 11: CAR-T FOR MYOSITIS & INTERSTITIAL LUNG DISEASE
CAR-T FOR MYOSITIS & INTERSTITIAL LUNG DISEASE
Open to view video.
Open to view video. Speaker: Jörg Henes, MD, PhD Head of the Rheumatology Department, Senior Physician of the Department of Medical Clinic II University of Tübingen, Germany
CAR-T FOR MYOSITIS & INTERSTITIAL LUNG DISEASE
Open to download resource.
Open to download resource. Speaker: Jörg Henes, MD, PhD Head of the Rheumatology Department, Senior Physician of the Department of Medical Clinic II University of Tübingen, Germany
Session 12: CAR-T IN SCLERODERMA
CAR-T IN SCLERODERMA
Open to view video.
Open to view video. Speaker: Alain Lescoat, MD, PhD Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, France
CAR-T IN SCLERODERMA
Open to download resource.
Open to download resource. Speaker: Alain Lescoat, MD, PhD Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, France
Session 13: CAR-T IN JUVENILE DERMATOMYOSITIS (Awaiting Speaker's Consent)
Session 14: PATIENT SELECTION AND ADWP EBMT GUIDELINES FOR CLINICAL PRACTICES
PATIENT SELECTION AND ADWP EBMT GUIDELINES FOR CLINICAL PRACTICES
Recorded 11/25/2025  |  60 minutes
Recorded 11/25/2025  |  60 minutes Speaker: Dominique Farge, MD, PhD ISCT Regional Vice-President, Europe Internal Medicine, St Louis Hospital, Paris-Cité University, France
PATIENT SELECTION AND ADWP EBMT GUIDELINES FOR CLINICAL PRACTICES
Open to download resource.
Open to download resource. Speaker: Dominique Farge, MD, PhD ISCT Regional Vice-President, Europe Internal Medicine, St Louis Hospital, Paris-Cité University, France
Session 15: B CELL TARGETED THERAPY IN INFLAMMATORY AUTOIMMUNE DISEASES OF THE CNS
B CELL TARGETED THERAPY IN INFLAMMATORY AUTOIMMUNE DISEASES OF THE CNS
Open to view video.
Open to view video. Speaker: Aiden Haghikia, MD, PhD Clinical Director, Department of Neurology, University Hospital Magdeburg, Germany
B CELL TARGETED THERAPY IN INFLAMMATORY AUTOIMMUNE DISEASES OF THE CNS
Open to download resource.
Open to download resource. Speaker: Aiden Haghikia, MD, PhD Clinical Director, Department of Neurology, University Hospital Magdeburg, Germany
Session 16: RESETTING THE IMMUNE REPERTOIRE IN NEUROLOGICAL AUTOIMMUNE DISEASES
RESETTING THE IMMUNE REPERTOIRE IN NEUROLOGICAL AUTOIMMUNE DISEASES
Open to view video.
Open to view video. Speaker: Paolo Muraro, MD, PhD Neuroimmunology and Neurology, Department of Brain Sciences –Faculty of Medicine, Imperial College London, United Kingdom
RESETTING THE IMMUNE REPERTOIRE IN NEUROLOGICAL AUTOIMMUNE DISEASES
Open to download resource.
Open to download resource. Speaker: Paolo Muraro, MD, PhD Neuroimmunology and Neurology, Department of Brain Sciences –Faculty of Medicine, Imperial College London, United Kingdom
Session 17: CAR-T IN MULTIPLE SCLEROSIS
CAR-T IN MULTIPLE SCLEROSIS
Recorded 11/25/2025  |  60 minutes
Recorded 11/25/2025  |  60 minutes Speaker: Christoph Heesen, MD, PhD Clinical and Rehabilitative MS Research, Head of Multiple Sclerosis Day Hospital, University Medical Center Hamburg-Eppendorf, Germany
CAR-T IN MULTIPLE SCLEROSIS
Open to download resource.
Open to download resource. Speaker: Christoph Heesen, MD, PhD Clinical and Rehabilitative MS Research, Head of Multiple Sclerosis Day Hospital, University Medical Center Hamburg-Eppendorf, Germany
Session 18: CAR-T IN MYASTHENIA GRAVIS, MNO AND STIFF SYNDROME (Awaiting Speaker's Consent)
Session 19: STATISTICAL CONSIDERATIONS FOR OPTIMAL CAR-T CLINICAL TRIAL DESIGN IN AUTOIMMUNE DISEASES
STATISTICAL CONSIDERATIONS FOR OPTIMAL CAR-T CLINICAL TRIAL DESIGN IN AUTOIMMUNE DISEASES
Recorded 11/25/2025  |  60 minutes
Recorded 11/25/2025  |  60 minutes Speaker: Lucie Biard, MD, PhD Department of Biostatistics, St Louis Hospital, Paris- Cité University, France
STATISTICAL CONSIDERATIONS FOR OPTIMAL CAR-T CLINICAL TRIAL DESIGN IN AUTOIMMUNE DISEASES
Open to download resource.
Open to download resource. Speaker: Lucie Biard, MD, PhD Department of Biostatistics, St Louis Hospital, Paris-Cité University, France
Session 20: SAFETY OF GENE MODIFIED IMMUNE CELLS: CONSIDERATIONS IN AUTOIMMUNE DISEASE
SAFETY OF GENE MODIFIED IMMUNE CELLS: CONSIDERATIONS IN AUTOIMMUNE DISEASE
Recorded 11/25/2025  |  60 minutes
Recorded 11/25/2025  |  60 minutes Speaker: Bruce Levine, PhD Barbara and Edward Netter Professor, University of Pennsylvania, United States
SAFETY OF GENE MODIFIED IMMUNE CELLS: CONSIDERATIONS IN AUTOIMMUNE DISEASE
Open to download resource.
Open to download resource. Speaker: Bruce Levine, PhD Barbara and Edward Netter Professor, University of Pennsylvania, United States
Session 21: CELL MANUFACTURING IN THE ACADEMIC SETTING
CELL MANUFACTURING IN THE ACADEMIC SETTING
Recorded 11/25/2025  |  60 minutes
Recorded 11/25/2025  |  60 minutes Speaker: Manel Juan, MD, PhD Head of Immunology Department, Hospital Clinic Barcelona, Spain
CELL MANUFACTURING IN THE ACADEMIC SETTING
Open to download resource.
Open to download resource. Speaker: Manel Juan, MD, PhD Head of Immunology Department, Hospital Clinic Barcelona, Spain
Session 22: REGULATORY CHALLENGES AND FRAMEWORK FOR CAR-T APPLICATION IN EUROPE (EMA)
REGULATORY CHALLENGES AND FRAMEWORK FOR CAR-T APPLICATION IN EUROPE (EMA)
Recorded 11/25/2025  |  60 minutes
Recorded 11/25/2025  |  60 minutes Speaker: Cristina Avendaño, MD, PhD Head of Clinical Pharmacology Department, Puerta de Hierro University Hospital, Spain
REGULATORY CHALLENGES AND FRAMEWORK FOR CAR-T APPLICATION IN EUROPE (EMA)
Open to download resource.
Open to download resource. Speaker: Cristina Avendaño, MD, PhD Head of Clinical Pharmacology Department, Puerta de Hierro University Hospital, Spain
Session 23: HOW TO DEAL WITH EXISTING REGISTRIES REPORTS AND REAL WORLD DATA ANALYSIS?
HOW TO DEAL WITH EXISTING REGISTRIES REPORTS AND REAL WORLD DATA ANALYSIS?
Recorded 11/25/2025  |  60 minutes
Recorded 11/25/2025  |  60 minutes Speaker: Raffaella Greco, MD Senior Hematologist, Hematology & Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Italy
HOW TO DEAL WITH EXISTING REGISTRIES REPORTS AND REAL WORLD DATA ANALYSIS?
Open to download resource.
Open to download resource. Speaker: Raffaella Greco, MD Senior Hematologist, Hematology & Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Italy
Course Survey
Course Evaluation Form
10 Questions
10 Questions For detailed information on how your data is retained, please refer to our program policies and guidelines using the below link in relation to Request for Record and Data Retrieval Policy and Our Privacy Policy: https://lms.isctglobal.org/Policies
Certificate of Participation
No credits available  |  Certificate available
No credits available  |  Certificate available
Course Assessment
Quiz
34 Questions  |  Unlimited attempts  |  10/34 points to pass
34 Questions  |  Unlimited attempts  |  10/34 points to pass The passing score for this quiz is 80%.
Course Completion Certificate
No credits available  |  Certificate available
No credits available  |  Certificate available Participants MUST complete all modules, session quizzes and course evaluation form to receive the Course Completion Certificate.